Skip to main content

Cibinqo Alternatives Compared

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Cibinqo (abrocitinib) Dupixent (dupilumab) Rinvoq (upadacitinib)
View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Cibinqo (abrocitinib) Dupixent (dupilumab) Rinvoq (upadacitinib)
Prescription only

Prescribed for Atopic Dermatitis. Cibinqo may also be used for purposes not listed in this medication guide.

Prescription only

Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, or prurigo nodularis. Injection site reactions and eye problems... View more

Prescription only

Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid... View more

More about Cibinqo (abrocitinib) More about Dupixent (dupilumab) More about Rinvoq (upadacitinib)
Ratings & Reviews

Cibinqo has an average rating of 8.6 out of 10 from a total of 5 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 0% reported a negative effect.

Dupixent has an average rating of 7.2 out of 10 from a total of 500 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 20% reported a negative effect.

Rinvoq has an average rating of 7.0 out of 10 from a total of 224 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 17% reported a negative effect.

View all 5 reviews

View all 500 reviews

View all 224 reviews

Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified.

View all Cibinqo side effects

View all Dupixent side effects

View all Rinvoq side effects
Drug Class
Generic Availability

No lower cost generic approved

N/A

No lower cost generic approved
Pricing and Coupons * Prices are without insurance
Quantity 30 tablet
Strength 50 mg
Per unit* $203.74
Cost* $6,112.15

View all Cibinqo prices

Quantity 2.28 mL
Strength 200 mg/1.14 mL
Per unit* $1,832.60
Cost* $4,178.32

View all Dupixent prices

Quantity 30 tablet, extended release
Strength 15 mg
Per unit* $235.30
Cost* $7,059.14

View all Rinvoq prices

Get free Discount Card

Get free Discount Card

Get free Discount Card

Dosage Forms
  • Oral tablet
  • Subcutaneous solution
  • Oral tablet, extended release
Brand Names

N/A

N/A

 Other upadacitinib brands include: Rinvoq LQ
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value.

5 hours

N/A

14 hours
CSA Schedule 1 View glossary of CSA terms
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
Pregnancy Category

Summary unavailable.

See the full pregnancy warnings document.

Summary unavailable.

See the full pregnancy warnings document.

Summary unavailable.

See the full pregnancy warnings document.
Drug Interactions

A total of 574 drugs are known to interact with Cibinqo:

  • 265 major drug interactions (925 brand and generic names)
  • 261 moderate drug interactions (886 brand and generic names)
  • 48 minor drug interactions (145 brand and generic names)

A total of 92 drugs are known to interact with Dupixent:

  • 43 major drug interactions (115 brand and generic names)
  • 40 moderate drug interactions (129 brand and generic names)
  • 9 minor drug interactions (37 brand and generic names)

A total of 596 drugs are known to interact with Rinvoq:

  • 380 major drug interactions (1250 brand and generic names)
  • 206 moderate drug interactions (844 brand and generic names)
  • 10 minor drug interactions (40 brand and generic names)
Alcohol/Food/Lifestyle Interactions
  • Abrocitinib may be taken with or without food. Smoking during treatment with abrocitinib may... View more

No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
  • Consumption of grapefruit, grapefruit juice, and supplements that contain grapefruit should be... View more
Disease Interactions
First Approval Date

January 14, 2022

March 28, 2017

August 16, 2019
WADA Class View classifications

N/A

N/A

N/A
More Information
Patient Resources
Professional Resources
Related Treatment Guide

1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Compare Drugs

To view a report comparing 3 (or more) medications, please sign in or create an account.

Create an account Sign In